Gritstone bio Inc (GRTS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Andrew R. Allen
Employees:
190
5858 HORTON STREET, SUITE 210, EMERYVILLE, CA 94608
(510) 871-6100

Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder and microsatellite stable, and colorectal cancers. The company is also developing SLATE, an off-the-shelf immunotherapy candidate for common solid tumors. In addition, it develops CORAL, a SARS-CoV-2 vaccine

Data derived from most recent annual or quarterly report
Market Cap 126.583 Million Shares Outstanding93.075 Million Avg 30-day Volume 1.067 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.35
Price to Revenue19.1861 Debt to Equity0.2713 EBITDA-126.617 Million
Price to Book Value2.0454 Operating Margin-1132.9595 Enterprise Value136.866 Million
Current Ratio5.535 EPS Growth0.107 Quick Ratio5.18
1 Yr BETA 1.8957 52-week High/Low 4.05 / 1.14 Profit Margin-1117.1475
Operating Cash Flow Growth-29.2296 Free Cash Flow to Firm (FCFF) TTM -105.525 Million Free Cash Flow to Equity (FCFE) TTM-66.595 Million
Altman Z-Score-3.8917
View SEC Filings from GRTS instead.

View recent insider trading info

Gritstone bio Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding GRTS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GRTS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-06-21 by COREY LAWRENCE
  • 4: filed on 2023-06-21 by FISHER CLARE
  • 4: filed on 2023-06-21 by RIZVI NAIYER
  • 4: filed on 2023-06-21 by KROGNES STEVE E.
  • 4: filed on 2023-06-21 by AGARWAL SHEFALI
  • 4: filed on 2023-05-24 by ECONOMIDES VASSILIKI
  • 4: filed on 2023-02-06 by JOOSS KARIN
  • 4: filed on 2023-02-06 by JONES ERIN
  • 4: filed on 2023-02-06 by HAWRYLUK MATTHEW
  • 4: filed on 2023-02-06 by ECONOMIDES VASSILIKI

    • Events (8k)

  • 8-K: filed on 2023-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-09-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-15:
    Item 8.01: Other Events
  • 8-K: filed on 2023-08-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-21:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-06:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-10:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-03-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 2.02: Results of Operations and Financial Condition

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    JONES ELAINE V

    • Director
    		 0 2023-06-16 1

    KROGNES STEVE E.

    • Director
    		 0 2023-06-16 1

    RIZVI NAIYER

    • Director
    		 0 2023-06-16 1

    AGARWAL SHEFALI

    • Director
    		 0 2023-06-16 1

    FISHER CLARE

    • Director
    		 0 2023-06-16 1

    COREY LAWRENCE

    • Director
    		 0 2023-06-16 1

    ECONOMIDES VASSILIKI SEE REMARKS

    • Officer
    		 214,058 2023-05-23 2

    ALLEN ANDREW R PRESIDENT AND CEO

    • Officer
    • Director
    		 2,306,025 2023-02-02 1

    JONES ERIN SEE REMARKS

    • Officer
    		 305,914 2023-02-02 1

    JOOSS KARIN SEE REMARKS

    • Officer
    		 630,147 2023-02-02 1

    HAWRYLUK MATTHEW SEE REMARKS

    • Officer
    		 248,311 2023-02-02 1

    CHO JAMES CHIEF ACCOUNTING OFFICER

    • Officer
    		 111,407 2023-02-02 1

    HEYMAN RICHARD A.

    • Director
    		 19,000 2022-06-17 0

    THOMPSON RAHSAAN EVP AND GENERAL COUNSEL

    • Officer
    		 174,138 2022-01-31 0

    WOIWODE THOMAS

    • Director
    		 4,006,022 2021-08-25 0

    LI JUDITH

    • Director
    		 19,000 2021-06-18 0

    ROUSSEAU RAPHAEL SEE REMARKS

    • Officer
    		 122,426 2021-05-27 0

    YELENSKY ROMAN SEE REMARKS

    • Officer
    		 234,672 2021-03-08 0

    YABANNAVAR VIJAY SEE REMARKS

    • Officer
    		 60,000 2021-03-08 0

    SIMON NICHOLAS

    • Director
    • 10% Owner
    		 0 2020-06-18 0

    BELLEMIN JEAN-MARC SEE REMARKS

    • Officer
    		 0 2020-02-25 0

    SVENNILSON PETER

    • Director
    • 10% Owner
    		 0 2019-06-19 0

    YELENSKY ROMAN SEE REMARKS

    YELENSKY ROMAN SEE REMARKS

    • Officer
    		 0 2019-02-13 0

    COLUMN GROUP II, LP

    COLUMN GROUP II GP, LP

    SVENNILSON PETER

    GOEDDEL DAVID V

    • Director
    • 10% Owner
    • GENERAL PARTNER MANAGING PARTNER
    		 3,102,934 2018-10-02 0

    REDMILE GROUP, LLC

    GREEN JEREMY

    • 10% Owner
    		 No longer subject to file 2018-10-02 0

    VERSANT VENTURE CAPITAL V, L.P.

    VERSANT VENTURE CAPITAL V (CANADA), LP

    VERSANT OPHTHALMIC AFFILIATES I, L.P.

    VERSANT AFFILIATES FUND V, L.P.

    • 10% Owner
    • GENERAL PARTNERGENERAL PARTNERGENERAL PARTNER
    		 3,102,929 2018-10-02 0

    CLARUS LIFESCIENCES III, L.P.

    CLARUS VENTURES III GP, L.P.

    CLARUS VENTURES III, LLC

    • 10% Owner
    • GENERAL PARTNERGENERAL PARTNER
    		 2,567,445 2018-09-28 0

    APHALE JAYANT SEE REMARKS

    • Officer
    		 0 2018-09-27 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    GRITSTONE BIO INC GRTS 2023-11-28 22:15:04 UTC 4.8249 0.4951 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 21:45:03 UTC 4.8249 0.4951 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 21:15:04 UTC 4.8249 0.4951 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 20:45:04 UTC 4.8249 0.4951 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 20:15:04 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 19:45:03 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 19:15:04 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 18:45:03 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 18:15:03 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 17:45:04 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 17:15:04 UTC 4.8239 0.4961 2100000
    GRITSTONE BIO INC GRTS 2023-11-28 16:45:04 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 16:15:04 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 15:45:03 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 15:15:03 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 14:45:04 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 14:15:04 UTC 4.8239 0.4961 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 13:45:04 UTC 4.8328 0.4872 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 13:15:03 UTC 4.8328 0.4872 2000000
    GRITSTONE BIO INC GRTS 2023-11-28 12:45:04 UTC 4.8328 0.4872 2000000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund GRTS -4900.0 shares, $-8428.0 2023-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments